Titan Pharmaceuticals
TTNP
#10544
Rank
HK$48.04 M
Marketcap
HK$36.12
Share price
-3.76%
Change (1 day)
17.38%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -HK$34.26

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -HK$34.39. In 2023 the company made an earnings per share (EPS) of -HK$58.05 an increase over its 2022 EPS that were of -HK$119.00.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$34.26
2023-HK$58.05-51.22%
2022-HK$119.00-15.61%
2021-HK$141.02-81.37%
2020-HK$756.79-77.52%
2019-HK$3,367-56.32%
2018-HK$7,709-59.51%
2017-HK$19,041-371.81%
2016HK$7,005-144.35%
2015-HK$15,794300%
2014-HK$3,949-121.54%
2013HK$18,332-151.38%
2012-HK$35,678-11.54%
2011-HK$40,331188.89%
2010-HK$13,961-10%
2009-HK$15,512
2007-HK$63,599-2.38%
2006-HK$65,151-39.13%
2005-HK$107,033-16.87%
2004-HK$128,750-22.43%
2003-HK$165,9794.9%
2002-HK$158,22361.9%
2001-HK$97,726-13.7%
2000-HK$113,23865.01%
1999-HK$68,626-35.87%
1998-HK$107,015-1824.71%
1997HK$6,205-102.4%
1996-HK$259,051

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.26-353.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$56.41-264.01%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-HK$11.12-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
HK$6.82-119.82%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-HK$1.96-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$30.48-11.39%๐Ÿ‡บ๐Ÿ‡ธ USA